OMNISCAN 287mg / ml injectible solution medication leaflet

V08CA03 gadodiamide • Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media

Gadodiamide is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to improve the visibility of organs and blood vessels. This medication helps obtain detailed images, making it easier to diagnose conditions such as tumors, inflammation, or central nervous system lesions.

Gadodiamide is administered intravenously, usually before or during the MRI procedure. The dose is determined by the doctor based on the patient's weight and general condition. The procedure is quick and generally well tolerated by most patients.

Side effects may include a sensation of warmth, metallic taste, nausea, or reactions at the injection site. In rare cases, severe allergic reactions or impaired kidney function may occur, especially in patients with pre-existing kidney disease. It is important to inform your doctor about any conditions or allergies before the examination.

Gadodiamide is an effective contrast agent for MRI, but its use requires careful medical supervision. Follow your doctor's instructions and report any unusual symptoms after the examination to prevent complications.

General data about OMNISCAN 287mg / ml

Substance: gadodiamide

Date of last drug list: 01-07-2014

Commercial code: W12009006

Concentration: 287mg / ml

Pharmaceutical form: injectible solution

Quantity: 10

Product type: original

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Concentrations available for gadodiamide

0.5mmol/ml, 287mg/ml